Recombinant method for the production of a monoclonal antibody to CD52 for the treatment of chronic lymphocytic leukemia

Details for Australian Patent Application No. 2006250887 (hide)

Owner Avestha Gengraine Technologies Pvt Ltd

Inventors Patell, Villoo Morawala

Agent Spruson & Ferguson

Pub. Number AU-A-2006250887

PCT Pub. Number WO2006/126068

Priority 625/CHE/2005 24.05.05 IN

Filing date 24 May 2006

Wipo publication date 30 November 2006

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/126068 Priority application(s): WO2006/126068

24 April 2008 Alteration of Name

  The name of the applicant has been altered to Avesthagen Limited

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006250888-A method for the production of a monoclonal antibody to CD20 for the treatment of B-cell lymphoma

2006250885-A recombinant method for production of an erythropoiesis stimulating protein